Drugs / FAB-9011
last change Oct 2011 re-read 3 minutes ago

FAB-9011

Vaccine

Developed for
influenza
Investigated by
Fluart Innovative Vaccine Ltd, Hungary

Trials 1

2012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT01408290 Sep → Oct 2011 influenza Fluart Innovative Vaccine Ltd, Hungary Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as FAB-9011 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01408290 ↗
Modality Vaccine “FAB-9011 trivalent influenza vaccine” NCT01408290 ↗